M. Schechter

M. Schechter, C. Archibald, M. Ofner, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Genotypic and Functional Impact of HIV-1 Adaptation to Its Host Population during the North American Epidemic

M. Carrington, B. Walker, J. Fuchs, 2014, PLoS genetics.

Physician Communication in Injectable Opioid Agonist Treatment: Collecting Patient Ratings With the Communication Assessment Tool

M. Schechter, D. Guh, D. Marsh, 2020, Journal of addiction medicine.

Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.

R. Hogg, J. Montaner, M. Schechter, 2004, International journal of epidemiology.

Rationale for evaluating North America's first medically supervised safer-injecting facility.

J. Montaner, M. Schechter, S. Strathdee, 2004, The Lancet. Infectious diseases.

Use of pooling, and outpatient laboratory specimens in an anonymous seroprevalence survey of HIV infection in British Columbia, Canada

M. Schechter, S. Strathdee, M. O’Shaughnessy, 1995, AIDS.

Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic

M. Carrington, B. Walker, J. Fuchs, 2015, Journal of Virology.

Females Experiencing Sexual and Drug Vulnerabilities Are at Elevated Risk for HIV Infection Among Youth Who Use Injection Drugs

M. Schechter, M. Tyndall, Kathy Li, 2002, Journal of acquired immune deficiency syndromes.

Using Pharmacoeconomic Analysis to Make Drug Insurance Coverage Decisions

M. Schechter, A. Anis, Tuhinur Rahman, 2012, PharmacoEconomics.

Responding to an Explosive HIV Epidemic Driven by Frequent Cocaine Injection: Is There a Role for Safe Injecting Facilities?

M. Schechter, E. Wood, T. Kerr, 2003 .

The Potential Public Health and Community Impacts of Safer Injecting Facilities: Evidence From a Cohort of Injection Drug Users

R. Hogg, M. Schechter, E. Wood, 2003, Journal of acquired immune deficiency syndromes.

Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

J. Montaner, M. Schechter, E. Wood, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America’s First Trial of Heroin-Assisted Treatment

M. Schechter, A. Anis, B. Nosyk, 2008, Journal of Urban Health.

The Cedar Project: Residential transience and HIV vulnerability among young Aboriginal people who use drugs.

M. Schechter, K. Jongbloed, M. Pearce, 2015, Health & place.

The Cedar Project: exploring the role of colonial harms and childhood maltreatment on HIV and hepatitis C infection in a cohort study involving young Indigenous people who use drugs in two Canadian cities

M. Schechter, N. Caron, E. Yoshida, 2021, BMJ Open.

Cango Lyec (Healing the Elephant): HIV incidence in post-conflict Northern Uganda

David S. Zamar, M. Schechter, N. Sewankambo, 2020, EClinicalMedicine.

Cango Lyec (Healing the Elephant): Gender Differences in HIV Infection in Post-conflict Northern Uganda

M. Schechter, N. Sewankambo, J. P. Ekwaru, 2018, Journal of acquired immune deficiency syndromes.

Gender Differences in HIV and Hepatitis C Related Vulnerabilities Among Aboriginal Young People Who Use Street Drugs in Two Canadian Cities

A. Mehrabadi, M. Schechter, M. Pearce, 2008, Women & health.

HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate.

M. Schechter, D. Lawrence, C. Tsoukas, 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting.

R. Hogg, J. Montaner, M. Schechter, 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

AIDS trials, civil liberties and the social control of therapy: should we embrace new drugs with open arms?

M. Schechter, D. Salisbury, 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency

M. Schechter, D. Guh, Kirsten Marchand, 2015, Substance Abuse Treatment, Prevention, and Policy.

Survival after age 80.

R. Hogg, M. Schechter, A. Sallar, 1996, The New England journal of medicine.

The quality of eight health status measures were compared for chronic opioid dependence.

M. Schechter, A. Anis, D. Guh, 2010, Journal of clinical epidemiology.

Determinants of sexual risk-taking among young HIV-negative gay and bisexual men.

R. Hogg, J. Montaner, M. Schechter, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

M. Schechter, E. Wood, M. Tyndall, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial

J. Singer, D. Owens, M. Schechter, 2011, PloS one.

The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS

B. Yip, R. Hogg, J. Montaner, 2000, PharmacoEconomics.

Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment

N. Bansback, M. Schechter, A. Anis, 2012, Canadian Medical Association Journal.

Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.

M. Schechter, A. Anis, B. Nosyk, 2010, Journal of substance abuse treatment.

Estimating the effect of treatment on quality of life in the presence of missing data due to drop-out and death

J. Singer, M. Schechter, J. Raboud, 1998, Quality of Life Research.

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

S. Sheps, M. Hayden, M. Schechter, 1993, The New England journal of medicine.

Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.

J. Singer, G. Innes, M. Schechter, 2002, The New England journal of medicine.

Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

M. Schechter, A. Anis, D. Guh, 2017, Drug and alcohol dependence.

The Vancouver Lymphadenopathy-AIDS Study: 5. Antecedent behavioural, clinical and laboratory findings in patients with AIDS and HIV-seropositive controls.

M. Schechter, M. O’Shaughnessy, K. Craib, 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy.

M. Schechter, E. Jeffries, W. Boyko, 1985, Canadian Medical Association journal.

Implications of the age range in a population-based BRCA1 testing program with eligibility based on family history of breast and ovarian cancer.

R. Gallagher, M. Schechter, J. Raboud, 2004, Genetic testing.

A computer model to simulate family history of breast/ovarian cancer in BRCA1 mutation carriers.

R. Gallagher, M. Schechter, J. Raboud, 2001, Mathematical biosciences.

Cost‐effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

N. Bansback, M. Schechter, A. Anis, 2018, Addiction.

Relation between hospital HIV/AIDS caseload and mortality among persons with HIV/AIDS in Canada.

R. Hogg, J. Montaner, M. Schechter, 1998, Clinical and investigative medicine. Medecine clinique et experimentale.

“They Don't See Our Feelings.” The Health Care Experiences of HIV-Positive Transgendered Persons

R. Hogg, M. Schechter, M. O’Shaughnessy, 1998 .

The changing spectrum of AIDS index diseases in Canada

R. Hogg, J. Montaner, M. Schechter, 1994, AIDS.

The Cedar Project: Negative health outcomes associated with involvement in the child welfare system among young Indigenous people who use injection and non-injection drugs in two Canadian cities

M. Schechter, N. Caron, K. Jongbloed, 2015, Canadian Journal of Public Health.

Response to “risk factor analysis of screening data”

C. Baines, A. Miller, M. Schechter, 1987 .

Low HIV‐1 proviral DNA burden detected by negative polymerase chain reaction in seropositive individuals correlates with slower disease progression

J. Montaner, M. Schechter, M. O’Shaughnessy, 1991, AIDS.

Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction

M. Schechter, M. Arella, S. Cassol, 1991, Journal of clinical microbiology.

Unexpected llung llesions iin h high rresolution c computed tomography ((HRTC) a among p patients w with a advanced HIV d disease

C. Staples, J. Hogg, J. Montaner, 1996 .

Unexpected lung lesions in high resolution computed tomography (HRTC) among patients with advanced HIV disease.

C. Staples, J. Hogg, J. Montaner, 1996, The European respiratory journal.

Incidence of endobronchial Kaposi's sarcoma.

R. Hogg, J. Montaner, M. Schechter, 1995, Chest.

Triple-combination antiretroviral therapy in sub-Saharan Africa

R. Hogg, M. Schechter, A. Anis, 1997, The Lancet.

Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.

R. Hogg, J. Montaner, M. Schechter, 2003, The Journal of infectious diseases.

A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080.

J. Montaner, M. Schechter, B. Conway, 1997, The Journal of infectious diseases.

Decreasing frequency but worsening mortality of acute respiratory failure secondary to AIDS-related Pneumocystis carinii pneumonia.

J. Montaner, M. Schechter, J. Ronco, 1994, Chest.

Association of alcohol consumption and cancer.

G. Matanoski, S. Green, M. Schechter, 1984, The New England journal of medicine.

A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.

M. Schechter, W. Jamieson, G. Growe, 1989, The New England journal of medicine.

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder

M. Schechter, A. Anis, D. Guh, 2017, Substance Abuse Treatment, Prevention, and Policy.

HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men

R. Hogg, M. Schechter, S. Strathdee, 1999, International journal of STD & AIDS.

BOOSTER IMMUNISATION FOR DIPHTHERIA AND TETANUS: NO EVIDENCE OF NEED IN ADULTS

M. Schechter, R. Mathias, 1985, The Lancet.

Development and Validation of a Patient Symptom Questionnaire to Facilitate Early Diagnosis of Thyroid-Associated Orbitopathy in Graves' Disease

J. Singer, M. Schechter, J. Rootman, 2008, Orbit.

HIV and ethnicity in Canada: is the HIV risk-taking behaviour of young foreign-born MSM similar to Canadian born MSM?

R. Hogg, M. Schechter, M. Alary, 2007, AIDS care.

CHANGES IN SEXUAL BEHAVIOUR AND FEAR OF AIDS

M. Schechter, E. Jeffries, W. Boyko, 1984, The Lancet.

Cigarette smoking and breast cancer: a case-control study of screening program participants.

A. Miller, M. Schechter, G. Howe, 1985, American journal of epidemiology.

AIDS risk taking behaviour among homosexual men : sociodemographic markers and policy implications

R. Hogg, J. Montaner, M. Schechter, 1992 .

Risk Factors Associated With HIV Infection Among Young Gay and Bisexual Men in Canada

R. Hogg, M. Schechter, M. Alary, 2001, Journal of acquired immune deficiency syndromes.

Clinical correlates of in vitro HIV‐1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial

J. Singer, J. Montaner, M. Wainberg, 1993, AIDS.

Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort

R. Hogg, J. Montaner, M. Schechter, 2005, AIDS care.

The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users

M. Schechter, P. Spittal, Heather Palis, 2015, Journal of addiction medicine.

in Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users.

M. Schechter, P. Spittal, Heather Palis, 2015 .

Rectal gonorrhoea asan independent risk factor forHIVinfection inacohort ofhomosexual men

J. Montaner, M. Schechter, S. Strathdee, 1995 .

Physician concurrence with primary care guidelines for persons with HIV disease

J. Singer, R. Hogg, J. Montaner, 1997, International journal of STD & AIDS.

Heterogeneity of physician agreement with recommended therapeutic guidelines for the management of HIV-associated disease.

R. Hogg, J. Montaner, M. Schechter, 1996, Antiviral therapy.

One step forward, two steps back.

M. Schechter, S. Strathdee, 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

B. Yip, R. Hogg, J. Montaner, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

A decade of research on the natural history of HIV infection: Part 2. Cofactors.

R. Hogg, J. Montaner, M. Schechter, 1996, Clinical and investigative medicine. Medecine clinique et experimentale.

The social determinants of emergency department and hospital use by injection drug users in Canada

R. Hogg, M. Schechter, A. Anis, 1999, Journal of urban health.

The Future Face of Coinfection: Prevalence and Incidence of HIV and Hepatitis C Virus Coinfection Among Young Injection Drug Users

J. Frankish, J. Montaner, M. Schechter, 2004, Journal of acquired immune deficiency syndromes.

Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users.

R. Hogg, M. Schechter, E. Wood, 2006, Health & place.

How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada

M. Schechter, E. Wood, M. O’Shaughnessy, 2004 .

Lost in Transition: HIV Prevalence and Correlates of Infection among Young People Living in Post-Emergency Phase Transit Camps in Gulu District, Northern Uganda

N. Sewankambo, M. Schechter, N. Kiwanuka, 2014, PloS one.

Aetiology of AIDS

Julio S. G. Montaner, E. Vittinghoff, K. Gelmon, 1993, The Lancet.

The role of secondary vaccine failures in measles outbreaks.

M. Schechter, R. Mathias, W. Meekison, 1989, American journal of public health.

The intervention for HIV prevention in young Indigenous people who use illicit drugs: study protocol for a randomized controlled trial.

M. Schechter, R. Lester, K. Jongbloed, 2016 .

“The Cango Lyec Project - Healing the Elephant”: HIV related vulnerabilities of post-conflict affected populations aged 13–49 years living in three Mid-Northern Uganda districts

M. Schechter, N. Sewankambo, N. Kiwanuka, 2016, BMC Infectious Diseases.

Bolus Thrombolytic Infusions During CPR

G. Innes, M. Schechter, J. Christenson, 1998 .

Antiretroviral medication use among injection drug users: two potential futures

Julio S. G. Montaner, R. Hogg, J. Montaner, 2000, AIDS.

HIV/AIDS mortality in Canada: evidence of gender, regional and local area differentials.

R. Hogg, J. Montaner, M. Schechter, 1996, AIDS.

Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how?

M. Schechter, J. Ruedy, J. Montaner, 1990, Annals of internal medicine.

Should we embrace new drugs with open arms? Experience from a community-based, open-arm, randomized clinical trial of combination antiretroviral therapy in advanced HIV disease.

R. Hogg, J. Montaner, M. Schechter, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Patterns of geographic mobility of persons with AIDS in Canada from time of AIDS index diagnosis to death.

R. Hogg, M. Schechter, J. Whitehead, 1997, Clinical and investigative medicine. Medecine clinique et experimentale.

INFLUENCE OF ZIDOVUDINE ON PROGRESSION TO AIDS IN COHORT STUDIES

Julio S. G. Montaner, M. Schechter, M. O’Shaughnessy, 1989, The Lancet.

Leaving hospital against medical advice among HIV-positive patients.

M. Schechter, A. Anis, D. Guh, 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.

M. Schechter, A. Anis, D. Guh, 2011, Addictive behaviors.

Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside? Yes there is, and in many other places too.

M. Schechter, P. Kendall, 2011, Canadian journal of public health = Revue canadienne de sante publique.

Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics

J. Rehm, M. Schechter, J. Strang, 2007, Journal of Urban Health.

Asthma Mortality in Canada, 1946 to 1990

J. Hogg, R. Hogg, J. Montaner, 1995 .

Factors associated with sex trade involvement among male participants in a prospective study of injection drug users

M. Schechter, E. Wood, P. Spittal, 2004, Sexually Transmitted Infections.

Requiring Help Injecting as a Risk Factor for HIV Infection in

M. Schechter, E. Wood, T. Kerr, 2003 .

Requiring Help Injecting as a Risk Factor for HIV Infection in the Vancouver Epidemic

M. Schechter, E. Wood, T. Kerr, 2003, Canadian journal of public health = Revue canadienne de sante publique.

Surviving the sex trade: A comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs

M. Schechter, J. Bruneau, M. O’Shaughnessy, 2003, AIDS care.

Needle exchange and difficulty with needle access during an ongoing HIV epidemic

R. Hogg, M. Schechter, E. Wood, 2002 .

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.

R. Hogg, J. Montaner, M. Schechter, 2002, AIDS.

An alcoholic patient who continues to drink

M. Schechter, S. Strathdee, S. Currie, 2006, BMJ : British Medical Journal.

Comparison of HIV-related vulnerabilities between former child soldiers and children never abducted by the LRA in northern Uganda

N. Sewankambo, M. Schechter, N. Kiwanuka, 2013, Conflict and Health.

Use of the Markov model to estimate the waiting times in a modified WHO staging system for HIV infection.

J. Montaner, M. Schechter, M. O’Shaughnessy, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system

J. Montaner, M. Schechter, K. Craib, 1992, AIDS.

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment

M. Schechter, D. Guh, D. Marsh, 2012, Harm Reduction Journal.

Injection drug use and despair through the lens of gender.

M. Schechter, P. Spittal, Martin T. Schechter, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.

M. Schechter, A. Anis, D. Guh, 2015, Addictive Behaviours.

Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

J. Bell, W. van den Brink, M. Schechter, 2015, British Journal of Psychiatry.

Drug users should be able to get heroin from the health system

M. Schechter, 2015, BMJ : British Medical Journal.

The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men.

J. Montaner, M. Schechter, R. Voigt, 1992, Clinical and investigative medicine. Medecine clinique et experimentale.

Adherence to guidelines for the prevention of HIV-related respiratory diseases.

J. Montaner, M. Schechter, M. O’Shaughnessy, 1996, The European respiratory journal.

Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations

R. Hogg, J. Montaner, M. Schechter, 2006, AIDS care.

Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases.

J. Fitzgerald, S. Vedal, J. Montaner, 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Hospital utilization and costs in a cohort of injection drug users.

M. Schechter, A. Anis, A. Palepu, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods.

M. Schechter, A. Anis, D. Guh, 2019, Journal of substance abuse treatment.

Cigarette smoking and breast cancer: case-control studies of prevalent and incident cancer in the Canadian National Breast Screening Study.

A. Miller, C. Baines, C. Wall, 1990, American journal of epidemiology.

Evaluation of diagnostic criteria for bacteriuria in acutely spinal cord injured patients undergoing intermittent catheterization.

M. Schechter, M. Gribble, N. M. McCallum, 1988, Diagnostic microbiology and infectious disease.

Indirect costs of HIV/AIDS mortality in Canada

R. Hogg, J. Montaner, M. Schechter, 1994, AIDS.

Sociodemographic correlates for risk-taking behaviour among HIV seronegative homosexual men.

R. Hogg, J. Montaner, M. Schechter, 1993, Canadian journal of public health = Revue canadienne de sante publique.

The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.

B. Wiggs, M. Schechter, M. O’Shaughnessy, 1985, Canadian Medical Association journal.

Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations.

W. Spitzer, M. Schechter, R. Dales, 1988, The American review of respiratory disease.

Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study

N. Bansback, M. Schechter, Scott Harrison, 2022, Patient preference and adherence.

PPA_A_391532 3405..3413

N. Bansback, M. Schechter, Scott Harrison, 2022 .

Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder

M. Schechter, A. Anis, D. Guh, 2019, Journal of addiction medicine.

Oral corticosteroids in patients with mild Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome (AIDS).

J. Montaner, M. Schechter, J. Ruedy, 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Cancer downwind from sour gas refineries: the perception and the reality of an epidemic.

W. Spitzer, M. Schechter, R. Dales, 1989, Environmental health perspectives.

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

R. Hogg, J. Montaner, M. Schechter, 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Impact of HIV infection and AIDS on death rates in British Columbia and Canada.

R. Hogg, J. Montaner, M. Schechter, 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men.

R. Hogg, M. Schechter, M. Miller, 2001, International journal of epidemiology.

Religion and HIV Sexual Risk Among Men Who Have Sex With Men in China

M. Schechter, Y. Ruan, R. Carpiano, 2016, Journal of acquired immune deficiency syndromes.

Intraarticular fractures of the calcaneus: value of CT findings in determining prognosis.

R. Buckley, M. Schechter, P. Munk, 1992, AJR. American journal of roentgenology.

Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

M. Schechter, S. Strathdee, S. Currie, 1999, AIDS.

Prevalence of HIV infection in provincial prisons in British Columbia.

M. Schechter, R. Mathias, D. Rothon, 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The Psychological Consequences of Predictive Testing for Huntington’s Disease

Sandi Wiggins, Michael R. Hayden, Martin T. Schechter, 1992 .

The Cedar Project *

M. Schechter, M. Pearce, Vicky Thomas, 2015, Violence against women.

Drastic elevations in mortality among female injection drug users in a Canadian setting

R. Hogg, J. Montaner, M. Schechter, 2006, AIDS care.

Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

R. Hogg, M. Schechter, E. Wood, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Impact of HIV Infection on Mortality in a Cohort of Injection Drug Users

M. Schechter, S. Currie, M. Tyndall, 2001, Journal of acquired immune deficiency syndromes.

Antiviral effect of double and triple drug combinations amongst HIV‐infected adults: lessons from the implementation of viral load‐driven antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 1998, AIDS.

Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents.

R. Hogg, J. Montaner, M. Schechter, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Antibiotic regimen as an independent risk factor for disseminated fungal infections in neutropenic patients in Brazil.

M. Schechter, M. Nucci, N. Spector, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

J. Montaner, M. Schechter, J. Ruedy, 1990, Annals of internal medicine.

A year of transformation in HIV/AIDS

M. Schechter, S. Montaner, 1995, The Lancet.

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.

B. Yip, R. Hogg, J. Montaner, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges

M. Schechter, A. Palepu, M. Tyndall, 2002, Journal of Urban Health.

Human amnion as a bioprosthesis for bile duct reconstruction in the pig.

M. Schechter, C. Scudamore, D. Owen, 1988, American journal of surgery.

Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa

Evan Wood, Paula Braitstein, Martin T Schechter, 2000, The Lancet.

The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people

M. Schechter, M. Pearce, Vicky Thomas, 2011, Canadian Medical Association Journal.

Inability to Access Addiction Treatment and Risk of HIV Infection Among Injection Drug Users

Julio S. G. Montaner, R. Hogg, M. Schechter, 2004, Journal of acquired immune deficiency syndromes.

The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities.

A. Mehrabadi, M. Schechter, P. Spittal, 2008, The International journal on drug policy.

Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men.

J. Montaner, M. Schechter, M. O’Shaughnessy, 1989, AIDS.

Preliminary Evaluation of a Scheme for Grading the Gross Morphology of the Human Intervertebral Disc

J. P. Thompson, M. Schechter, P. Bishop, 1990, Spine.

[Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].

P. Gøtzsche, M. Schechter, M. T. Schechter, 1993, Ugeskrift for laeger.

Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.

M. Schechter, P. Gøtzsche, 1992, BMJ.

Modified Delphi survey for decision analysis for prophylaxis of post-radiation osteonecrosis.

S. Sheps, M. Schechter, J. Epstein, 2002, Oral oncology.

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

R. Hogg, J. Montaner, M. Schechter, 1998, JAMA.

Percutaneous cecostomy for Ogilvie syndrome: laboratory observations and clinical experience.

G. Casola, M. Schechter, E. vanSonnenberg, 1990, Radiology.

Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort

B. Yip, R. Hogg, J. Montaner, 2006, AIDS.

Adherence to Antiretroviral Therapy and Cd4 T-Cell Count Responses among HIV-Infected Injection Drug Users

B. Yip, R. Hogg, J. Montaner, 2004, Antiviral therapy.

Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996

Evan Wood, Martin T Schechter, R. Hogg, 2002, AIDS.

Comparison of Costs of Strategies for Measuring Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma by Using Amplicor and Ultra Direct Assays

P. Harrigan, R. Hogg, J. Montaner, 1998, Journal of Clinical Microbiology.

Incidence and prognostic significance of symptomatic primary human immunodeficiency virus type 1 infection in homosexual men.

J. Kaldor, M. Schechter, I. Keet, 1997, The Journal of infectious diseases.

Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection

M. Schechter, S. Strathdee, S. Currie, 2022 .

Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda

M. Schechter, N. Sewankambo, K. Jongbloed, 2021, PloS one.

Aerosol pentamidine-induced bronchoconstriction. Predictive factors and preventive therapy.

J. Montaner, M. Schechter, J. Ruedy, 1991, Chest.

Associations of age, immunosuppression, and AIDS among homosexual men in the Tricontinental Seroconverter Study.

J. Kaldor, M. Schechter, P. Veugelers, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Geographic and birth cohort associations of Kaposi's sarcoma among homosexual men in Canada.

M. Schechter, C. Archibald, S. Marion, 1991, American journal of epidemiology.

Issues in the design of trials of therapies for subjects with human immunodeficiency virus infection that use plasma RNA level as an outcome.

J. Singer, J. Montaner, M. Schechter, 1997, The Journal of infectious diseases.

Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection.

J. Montaner, M. Schechter, B. Conway, 1996, The Journal of infectious diseases.

Diagnostic utility of lymphocyte subset analysis in AIDS case finding.

B. Wiggs, M. Schechter, W. Boyko, 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The Cedar Project: Relationship between child apprehension and attempted suicide among young Indigenous mothers impacted by substance use in two Canadian cities

M. Schechter, M. Guhn, K. Jongbloed, 2021, PloS one.

The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities

M. Schechter, M. Pearce, P. Spittal, 2012, BMC Public Health.

Sexual violence among a cohort of injection drug users.

R. Hogg, M. Schechter, P. Braitstein, 2003, Social science & medicine.

Needle exchange is not enough: lessons from the Vancouver injecting drug use study

Julio S. G. Montaner, M. Schechter, S. Strathdee, 1997, AIDS.

The Cedar Project: historical trauma, sexual abuse and HIV risk among young Aboriginal people who use injection and non-injection drugs in two Canadian cities.

M. Schechter, M. Pearce, P. Spittal, 2008, Social science & medicine.

The Cedar Project: resilience in the face of HIV vulnerability within a cohort study involving young Indigenous people who use drugs in three Canadian cities

M. Schechter, K. Jongbloed, M. Pearce, 2015, BMC Public Health.

The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities

M. Schechter, P. Spittal, K. Craib, 2007, International journal of circumpolar health.

HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response.

J. Frankish, M. Schechter, E. Wood, 2005, Canadian journal of public health = Revue canadienne de sante publique.

The Cedar Project: correlates of attempted suicide among young Aboriginal people who use injection and non-injection drugs in two Canadian cities

M. Schechter, M. Pearce, P. Spittal, 2009, International journal of circumpolar health.

Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.

Evan Wood, Kathy Li, Martin T Schechter, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) mortality in industrialized nations, 1987-1991.

R. Hogg, J. Montaner, M. Schechter, 1998, International journal of epidemiology.

Recent Incarceration Independently Associated with Syringe Sharing by Injection Drug Users

J. Montaner, M. Schechter, E. Wood, 2005, Public health reports.

Incarceration, Addiction and Harm Reduction: Inmates Experience Injecting Drugs in Prison

M. Schechter, M. O’Shaughnessy, P. Spittal, 2005, Substance use & misuse.

Sexual Risk Profile of Young Men in Vancouver, British Columbia, Who Have Sex with Men and Inject Drugs

R. Hogg, M. Schechter, M. Miller, 2004, AIDS and Behavior.

Binge Drug Use Independently Predicts HIV Seroconversion Among Injection Drug Users: Implications for Public Health Strategies

J. Frankish, M. Schechter, E. Wood, 2006, Substance use & misuse.

Determinants of HIV seroconversion in drug users during a period of rising prevalence in Vancouver

M. Schechter, C. Archibald, M. Ofner, 1997 .

Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users.

P. Harrigan, C. Alexander, J. Montaner, 1999, AIDS.

An anonymous seroprevalence survey of HIV infection among pregnant women in British Columbia and the Yukon Territory.

M. Schechter, S. Marion, M. O’Shaughnessy, 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Cango Lyec (Healing the Elephant): Probable post-traumatic stress disorder (PTSD) and depression in Northern Uganda five years after a violent conflict

N. Sewankambo, M. Schechter, K. Jongbloed, 2022, Journal of migration and health.

Sexual violence among two populations of men at high risk of HIV infection

R. Hogg, M. Schechter, P. Braitstein, 2006, AIDS care.

Experiences of the HIV Cascade of Care Among Indigenous Peoples: A Systematic Review

M. Schechter, R. Lester, K. Jongbloed, 2019, AIDS and Behavior.

The Cedar Project: mortality among young Indigenous people who use drugs in British Columbia

David S. Zamar, M. Schechter, E. Yoshida, 2017, Canadian Medical Association Journal.

The Cedar Project: Historical, structural and interpersonal determinants of involvement in survival sex work over time among Indigenous women who have used drugs in two Canadian cities.

M. Schechter, K. Jongbloed, M. Pearce, 2020, The International journal on drug policy.

The Cedar Project: exploring determinants of psychological distress among young Indigenous people who use drugs in three Canadian cities

M. Schechter, K. Jongbloed, M. Pearce, 2018, Global Mental Health.

The Cedar Project WelTel mHealth intervention for HIV prevention in young Indigenous people who use illicit drugs: study protocol for a randomized controlled trial

M. Schechter, R. Lester, K. Jongbloed, 2016, Trials.

The Cedar Project: impacts of policing among young Aboriginal people who use injection and non-injection drugs in British Columbia, Canada.

M. Schechter, K. Jongbloed, M. Pearce, 2013, The International journal on drug policy.

The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.

M. Schechter, Kathy Li, P. Spittal, 2011, Drug and alcohol review.

HIV incidence and associated risk factors among young injection drug users.

M. Schechter, M. Tyndall, Kathy Li, 2002, AIDS.

Evaluation of a postocclusive reactive circulatory hyperaemia (PORCH) test for the assessment of ulnar collateral circulation

S. Sheps, M. Schechter, H. Vaghadia, 1988, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.

M. Schechter, A. Anis, D. Guh, 2010, Drug and alcohol dependence.

he effect of motivational status on treatment outcome in the North American piate Medication Initiative ( NAOMI ) study

M. Schechter, J. Geller, A. Anis, 2010 .

Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.

M. Schechter, A. Anis, D. Guh, 2010, Journal of substance abuse treatment.

Characteristics and Response to Treatment among Aboriginal People Receiving Heroin-assisted Treatment

M. Schechter, A. Anis, D. Guh, 2010 .

Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment

M. Schechter, J. Foreman, Kirsten Marchand, 2020, Substance abuse treatment, prevention, and policy.

Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review

M. Schechter, D. Marsh, Kirsten Marchand, 2019, Substance Abuse Treatment, Prevention, and Policy.

Modelling the Potential Economic Impact of Viral Load—Driven Triple Drug Combination Antiretroviral Therapy

B. Yip, R. Hogg, J. Montaner, 1998, PharmacoEconomics.

Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection.

R. Hogg, J. Montaner, M. Schechter, 1997, Journal of Infectious Diseases.

Diagnostic testing revisited: pathways through uncertainty.

M T Schechter, S B Sheps, S. Sheps, 1985, Canadian Medical Association journal.

The impact of a police presence on access to needle exchange programs.

M. Schechter, E. Wood, T. Kerr, 2003, Journal of acquired immune deficiency syndromes.

Determinants of geographic mobility among participants in a population-based HIV/AIDS drug treatment program.

R. Hogg, J. Montaner, M. Schechter, 2000, Health & place.

Barriers to use of free antiretroviral therapy in injection drug users.

B. Yip, R. Hogg, J. Montaner, 1998, JAMA.

Lower socioeconomic status and shorter survival following HIV infection

Julio S. G. Montaner, R. Hogg, M. Schechter, 1994, The Lancet.

Decline in deaths from AIDS due to new antiretrovirals

B. Yip, R. Hogg, J. Montaner, 1997, The Lancet.

Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals.

J. Montaner, M. Schechter, J. Raboud, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Sensitivity, Specificity, and Predictive Value

M. T. Schechter, M. Schechter, 1998 .

Evaluation of the Diagnostic Process

M. Schechter, 1986 .

The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme.

R. Hogg, J. Montaner, M. Schechter, 1998, International journal of STD & AIDS.

Human immunodeficiency virus infection and the acquired immune deficiency syndrome: A review

M. Schechter, R. Coates, 1988 .

Sexual modes of transmission of the human immunodeficiency virus (HIV)

M. Schechter, R. Coates, 1988 .

CAN HTLV-III BE TRANSMITTED ORALLY?

M. Schechter, B. Willoughby, B. Douglas, 1986, The Lancet.

AIDS: the fictions, the facts.

M. Schechter, 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.

M. Schechter, M. O’Shaughnessy, K. Craib, 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.

Ccfp, B. Wiggs, M. Schechter, 1985, Canadian Medical Association journal.

Susceptibility to AIDS progression appears early in HIV infection

J. Montaner, M. Schechter, M. O’Shaughnessy, 1990, AIDS.

Is the Human Immunodeficiency Virus ‐Related Kaposi's Sarcoma Epidemic Coming to an End? Insights from the Tricontinental Seroconverter Study

M. Schechter, S. Strathdee, A. Moss, 1995, Epidemiology.

Long-term non-progression in HIV infection

Julio S. G. Montaner, R. Hogg, M. Schechter, 1995, The Lancet.

Patterns of sexual behavior and condom use in a cohort of homosexual men.

M. Schechter, M. O’Shaughnessy, K J Craib, 1988, American journal of public health.

Elevated rates of HIV infection among young Aboriginal injection drug users in a Canadian setting

M. Schechter, S. Strathdee, E. Wood, 2006, Harm reduction journal.

Evidence for a Sexually Transmitted Cofactor for AIDS-Related Kaposi's Sarcoma in a Cohort of Homosexual Men

J. Montaner, M. Schechter, C. Archibald, 1992, Epidemiology.

HIV infection and risk behaviours among young gay and bisexual men in Vancouver.

R. Hogg, M. Schechter, S. Strathdee, 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Risk factors for Kaposi's sarcoma in the Vancouver Lymphadenopathy-AIDS Study.

M. Schechter, C. Archibald, M. O’Shaughnessy, 1990, Journal of acquired immune deficiency syndromes.

The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.

M. Schechter, M. O'Shaughnessy, E. Jeffries, 1985, Canadian Medical Association journal.

Differences in time from HIV seroconversion to CD4+ lymphocyte end‐points and AIDS in cohorts of homosexual men

D. Cooper, M. Schechter, P. Veugelers, 1993, AIDS.

Limited usefulness of lymphocytopenia in screening for AIDS in hospital patients.

M. Schechter, W. Boyko, P. Constance, 1985, Canadian Medical Association journal.

Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters

M. Schechter, A. McNulty, P. Veugelers, 1996, AIDS.

THROUGH THE LOOKING GLASS : THE HEALTH AND SOCIO-ECONOMIC STATUS OF HEPATITIS C POSITIVE TRANSFUSION RECIPIENTS , 1986-1990

R. Hogg, M. Schechter, M. O’Shaughnessy, 1999 .

History of Treatment Access and Drug Use among Participants in a Trial Testing Injectable Opioids under Supervision for Long-Term Heroin Injectors

M. Schechter, A. Anis, D. Guh, 2015 .

Sustained increase in HIV-1 incidence since 2000 among men who have sex with men in British Columbia, Canada.

R. Hogg, M. Schechter, G. Ogilvie, 2005, Journal of acquired immune deficiency syndromes.

Evaluation of booking systems for elective surgery using simulation experiments.

Victor Sanchez, Lisa Kuramoto, Adrian R Levy, 2008, Healthcare policy = Politiques de sante.

Ethnicity and HIV vulnerabilities among men who have sex with men in China

M. Schechter, Y. Ruan, R. Carpiano, 2018, AIDS care.

Staging for antiretroviral therapy among HIV-infected drug users.

R. Hogg, J. Montaner, M. Schechter, 2004, JAMA.

Proportional hazards frailty models for recurrent methadone maintenance treatment.

Y. MacNab, M. Schechter, A. Anis, 2009, American journal of epidemiology.

Contribution Proportional Hazards Frailty Models for Recurrent Methadone Maintenance Treatment

Y. MacNab, M. Schechter, A. Anis, 2009 .

Adherence to clinical guidelines for the therapeutic management of HIV disease.

J. Singer, R. Hogg, J. Montaner, 1997, Clinical and investigative medicine. Medecine clinique et experimentale.

Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.

M. Schechter, A. Anis, D. Guh, 2010, Canadian journal of public health = Revue canadienne de sante publique.

Impact of HIV infection on mortality in a cohort of injection drug users.

M. Schechter, S. Currie, M. Tyndall, 2001 .

The Cedar Project: Understanding Barriers to Consistent Condom use over Time in a Cohort of Young Indigenous People who use Drugs

M. Schechter, P. Spittal, C. Richardson, 2013 .

Impacts of intensified police activity on injection drug users: Evidence from an ethnographic investigation

Thomas Kerr, Will Small, Martin T. Schechter, 2006 .

Science, Ideology, and Needle Exchange Programs

M. Schechter, 2002 .

Displacement of Canada's largest public illicit drug market in response to a police crackdown

R. Hogg, J. Montaner, M. Schechter, 2004, Canadian Medical Association Journal.

Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control

M. Schechter, M. Tyndall, Kathy Li, 2002, Sexually transmitted infections.

The health care and fiscal costs of the illicit drug use epidemic: The impact of conventional drug control strategies, and the potential of a comprehensive approach

M. Schechter, E. Wood, T. Kerr, 2003 .

NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America

M. Schechter, E. Oviedo-Joekes, Candice C Gartry, 2009, Harm reduction journal.

Satellite Needle Distribution Among Injection Drug Users: Policy and Practice in Two Canadian Cities

M. Schechter, J. Bruneau, M. Tyndall, 2002, Journal of acquired immune deficiency syndromes.

Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver.

M. Schechter, C. Archibald, M. Ofner, 1997, International journal of STD & AIDS.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long‐term opioid dependence

M. Schechter, A. Anis, D. Guh, 2018, Drug and alcohol review.

HIV-Positive Injection Drug Users Who Leave the Hospital Against Medical Advice: The Mitigating Role of Methadone and Social Support

M. Schechter, A. Anis, D. Guh, 2004, Journal of acquired immune deficiency syndromes.

Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach.

M. Schechter, D. Guh, D. Marsh, 2020, Drug and alcohol dependence.

War and HIV: Sex and gender differences in risk behaviour among young men and women in post-conflict Gulu District, Northern Uganda

N. Sewankambo, M. Schechter, N. Kiwanuka, 2014, Global public health.

Patient-centred care for addiction treatment: a scoping review protocol

M. Schechter, D. Marsh, Kirsten Marchand, 2018, BMJ Open.

The Role of Gender in Suicidal Ideation among Long-term Opioid Users

M. Schechter, P. Spittal, Heather Palis, 2017, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991 – 2000

Adrian R Levy, Martin T Schechter, A. Levy, 2005, BMC health services research.

Combining pooling and alternative algorithms in seroprevalence studies

M. Schechter, J. Raboud, C. Sherlock, 1993, Journal of clinical microbiology.

Predictors of treatment allocation guesses in a randomized controlled trial testing double-blind injectable hydromorphone and diacetylmorphine for severe opioid use disorder

M. Schechter, A. Anis, D. Guh, 2017 .

Average Annual Drug Cost and its Determinants in a Population Based Cohort of HIV—Positive Adult Men and Women

B. Yip, R. Hogg, J. Montaner, 1998, PharmacoEconomics (Auckland).

Letters to the Editor

B. Yip, R. Hogg, J. Montaner, 1998 .

Learning about HIV-2

M. Schechter, M. O'shaughnessy, 1994, The Lancet.

Predictors of early hospital readmission in HIV-infected patients with pneumonia

M. Schechter, A. Anis, A. Palepu, 2003, Journal of General Internal Medicine.

NAOMI—Her time has come

M. Schechter, 2002, Journal of Urban Health.

NAOMI--her time has come. North American Opiate Medication Initiative.

M. Schechter, 2002, Journal of urban health : bulletin of the New York Academy of Medicine.

The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users

Julio S. G. Montaner, R. Hogg, M. Schechter, 2004 .

Adjunctive Corticosteroid Therapy Decreases Lung Permeability in Patients with AIDS-Related Pneumocystis carinii Pneumonia

J. Montaner, M. Schechter, S. Guillemi, 1995 .

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder

M. Schechter, A. Anis, D. Guh, 2018, Addictive behaviors reports.

Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care.

R. Hogg, J. Montaner, M. Schechter, 1994, Journal of clinical epidemiology.

Subjective fears and objective data: an epidemiologic study of environmental health concerns.

W. Spitzer, M. Schechter, R. Dales, 1987, Transactions of the Association of American Physicians.

An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial.

J. Singer, B. Gazzard, M. Youle, 2003, Controlled clinical trials.

Estimating the extent of underreporting in AIDS surveillance.

D. Gertig, M. Schechter, S. Marion, 1991, AIDS.

The effect of waiting time on pain intensity after elective surgical lumbar discectomy.

Jacek A Kopec, Adrian R Levy, Martin T Schechter, 2013, The spine journal : official journal of the North American Spine Society.

One world, one hope: the cost of providing antiretroviral therapy to all nations

R. Hogg, J. Montaner, M. Schechter, 1998, AIDS.

A comparison of the new Federal Guidelines regulating supervised injection site research in Canada and the Tri-Council Policy Statement on Ethical Conduct for Research Involving Human Subjects

M. Schechter, E. Wood, T. Christie, 2004 .

M. Schechter, A. Anis, D. Guh, 2011, Drug and alcohol dependence.

The Vancouver Lymphadenopathy-AIDS Study: 7. Clinical and laboratory features of 87 cases of primary HIV infection.

M. Schechter, K. Craib, M. O'Shaughnessey, 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Longitudinal Patterns of Sexual Behavior and Condom Use in a Cohort of HIV‐Negative Gay and Bisexual Men in Vancouver, British Columbia, Canada, 1995‐2000

R. Hogg, M. Schechter, S. Strathdee, 2001, Journal of acquired immune deficiency syndromes.

Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine

R. Hogg, M. Schechter, M. Alary, 2005, Canadian Medical Association Journal.

Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men.

R. Hogg, M. Schechter, M. Miller, 2003, AIDS.

Respiratory health of a population living downwind from natural gas refineries.

W. Spitzer, M. Schechter, R. Dales, 1989, The American review of respiratory disease.

The Alcohol Use Disorders Identification Test (AUDIT): Exploring the Factor Structure and Cutoff Thresholds in a Representative Post-Conflict Population in Northern Uganda

M. Schechter, P. Spittal, A. Katamba, 2016, Alcohol and alcoholism.

The Effect of Compensation Status on Waiting Time for Elective Surgical Lumbar Discectomy

A. Levy, J. Kopec, M. Schechter, 2009, Spine.

Retinopathy of prematurity: a new epidemic?

S. Sheps, A. Mccormick, M. Schechter, 1989, Pediatrics.

A chance to stop and breathe: participants’ experiences in the North American Opiate Medication Initiative clinical trial

M. Schechter, A. Anis, J. Chettiar, 2014, Addiction Science & Clinical Practice.

THE QUALITY OF INITIAL FUNCTION FOLLOWING RENAL TRANSPLANTATION DETERMINED BY CREATININE ELIMINATION KINETICS: COMPARISON OF MINNESOTA ANTILYMPHOCYTE GLOBULIN AND CYCLOSPORINE INDUCTION IMMUNOSUPPRESSION

M. Schechter, C. Scudamore, D. Landsberg, 1991, Transplantation.

A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.

M. Schechter, D. Guh, D. Marsh, 2021, Journal of substance abuse treatment.

The end of the line: has rapid transit contributed to the spatial diffusion of HIV in one of Canada's largest metropolitan areas?

R. Hogg, J. Montaner, M. Schechter, 2000, Social science & medicine.

Access to health care and geographic mobility of HIV/AIDS patients.

R. Hogg, M. Schechter, S. Strathdee, 1995, AIDS patient care.

Estimating Risk and Prognosis

M. Schechter, S. Marion, 1998 .

Risk and Prognosis

M. Schechter, S. Marion, 1991 .

Do dual nucleoside regimens have a role in an era of plasma viral load-driven antiretroviral therapy?

R. Hogg, J. Montaner, M. Schechter, 1998, The Journal of infectious diseases.

Comparison of sexual behaviors, unprotected sex, and substance use between two independent cohorts of gay and bisexual men

R. Hogg, M. Schechter, S. Strathdee, 2000, AIDS.

Selection of women at high risk of breast cancer for initial screening.

A. Miller, C. Baines, A. Miller, 1986, Journal of chronic diseases.

The Cedar Project: Sexual Vulnerabilities Among Aboriginal Young People Involved in Illegal Drug Use in Two Canadian Cities

Shannon N. Waters, M. Schechter, P. Spittal, 2012, Canadian Journal of Public Health.

How many persons in Canada have been infected with human immunodeficiency virus? An exploration using backcalculation methods.

M. Schechter, S. Marion, M. Ricketts, 1992, Clinical and investigative medicine. Medecine clinique et experimentale.

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment

M. Schechter, D. Marsh, Heather Palis, 2021, Substance Abuse Treatment, Prevention, and Policy.

The antiviral effect of ritonavir and saquinavir incombination amongst HIV‐infected adults: results from a community‐based study

R. Hogg, J. Montaner, M. Schechter, 1998, AIDS.

AIDStrials, civil liberties andthesocial control oftherapy: Should weembrace newdrugs withopenarms?

M. Schechter, D. Salisbury, 1990 .

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment

M. Schechter, A. Anis, D. Guh, 2014, Substance Abuse Treatment, Prevention, and Policy.

Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. Canadian HIV Trials Network A002 Study Group.

J. Singer, J. Montaner, M. Schechter, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Impact of Missing Data Due to Dropouts on Estimates of the Treatment Effect in a Ranomized Trial of Antiretroviral Therapy for HIV-Infected Individuals

J. Singer, J. Montaner, M. Schechter, 1996 .

Didanosine Compared with Continued Zidovudine Therapy for HIV-Infected Patients with 200 to 500 CD4 Cells/mm3: A Double-Blind, Randomized, Controlled Trial

M. Wainberg, M. Schechter, H. Salomón, 1995, Annals of Internal Medicine.

Practice patterns of family physicians with 2-year residency v. 1-year internship training: do both roads lead to Rome?

S. Sheps, M. Schechter, R. Sizto, 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP.

J. Montaner, M. Schechter, J. Ronco, 1992, Chest.

Grading clinical research: a midterm report card.

S. Sheps, M. Schechter, 1984, Canadian Medical Association journal.

Appraising New Information

V. Lawrence, M. Schechter, F. Leblanc, 1998 .